医学
溶栓
冲程(发动机)
闭塞
急性中风
纤溶剂
血管内治疗
心脏病学
外科
内科学
动脉瘤
心肌梗塞
组织纤溶酶原激活剂
机械工程
工程类
作者
Salwa El Tawil,Keith W. Muir
出处
期刊:Clinical Medicine
[Royal College of Physicians]
日期:2017-04-01
卷期号:17 (2): 161-165
被引量:75
标识
DOI:10.7861/clinmedicine.17-2-161
摘要
The likelihood of disability-free recovery after acute ischemic stroke is significantly improved by reperfusion either by intravenous thrombolytic drug treatment or with endovascular mechanical thrombectomy in selected cases. The use of intravenous thrombolysis is limited by the short treatment window and you need to assess individual balance of benefit and risk of symptomatic intracranial haemorrhage. Benefit is greater for shorter onset-to-reperfusion time intervals, requiring optimisation of pre-hospital and in-hospital pathways. Symptomatic haemorrhage is more likely with more severe strokes, but a greater proportion of patients are left free of disability than suffer a treatment-related haemorrhage at all levels of severity. Extracranial haemorrhage and orolingual angioedema are less common complications. Endovascular mechanical thrombectomy can be used in selected patients with imaging-proven large artery occlusion. Successful therapy depends on well-organised services that can deliver treatment within a short time window at centres with adequate expertise to perform the procedure.
科研通智能强力驱动
Strongly Powered by AbleSci AI